等待开盘 04-01 09:30:00 美东时间
+0.100
+1.03%
今日重点评级关注:Piper Sandler:维持Allogene疗法"超配"评级,目标价从7美元升至8美元;B. Riley证券:维持Oncology Institute"买入"评级,目标价从6美元升至8美元
03-16 18:19
JP Morgan analyst Richard Shane maintains Palmer Square Capital BDC (NYSE:PSBD) with a Neutral and lowers the price target from $11.5 to $10.
03-14 00:06
今日重点评级关注:韦德布什:维持TScan Therapeutics"跑赢大市"评级,目标价从4美元升至5美元;HC Wainwright & Co.:维持莱斯康制药"买入"评级,目标价从4美元升至6美元
03-06 11:58
RBC Capital analyst Kenneth S. Lee maintains Palmer Square Capital BDC (NYSE:PSBD) with a Sector Perform and lowers the price target from $13 to $12.
03-05 23:35
Palmer Square Capital BDC (NYSE:PSBD) reported quarterly earnings of $0.41 per share which met the analyst consensus estimate. This is a 8.89 percent decrease over earnings of $0.45 per share from the same period last
02-26 20:04
Palmer Square Capital BDC estimates NAV per share at 1448 as of January 31 2026 Palmer Square Capital BDC Inc. reported an unaudited estimated net asset value (NAV) of $14.48 per common share as of Jan. 31, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative
02-19 05:18
Palmer Square Capital BDC Inc. to Release Earnings and Host Conference Call Palmer Square Capital BDC Inc. will release its financial results for the fourth quarter and full year ended December 31, 2025, before the market opens on Thursday, February 26, 2026. Results will be available on the Palmer
01-28 05:05
Palmer Square Capital BDC Inc. (NYSE: PSBD) ("Palmer Square" or the "Company"), an externally managed business development company, today announced that its Board of Directors has declared a fourth quarter 2025
2025-12-23 21:36
Top Wall Street analysts changed their outlook on these top names. For a comple...
2025-11-26 20:38
今日重点评级关注:富国银行:维持Annexon"超配"评级,目标价从14美元升至27美元;瑞穗:上调Relmada Therapeutics评级至"跑赢大市",目标价从1美元升至10美元
2025-11-20 10:28